显示所有

更新免疫参考页：流感

MVEC’s influenza reference page has been updated to include the latest recommendations and advice for the 2026 season. This includes a summary of vaccine brand for use in each age group as well as commonly asked questions.

Annual influenza vaccination is recommended for everyone aged 6 months and older. Influenza infection can cause a spectrum of symptoms, from mild cough and cold features to systemic illnesses with multiple complications. Pregnant women, children under 5 years, those aged over 65 years, people with underlying medical conditions, and Aboriginal and Torres Strait Islander peoples carry the highest rates of morbidity and mortality within Australia.

MVEC：流感

(NB: translated versions of the updated influenza reference page will be available soon)

经过 艾丽丝·布莱克

Benchmarque Group: Launceston immunisation seminar

Register now for Benchmarque Group’s 1-day immunisation seminar to be held in Launceston on 15 April 2026.

Learn more and register on the Benchmarque Group event page. 

经过 艾丽丝·布莱克

SKAI: Talking with parents about human papillomavirus (HPV) vaccination

This recently published conversation guide aims to help immunisation providers engage confidently with parents and carers about the importance of timely human papillomavirus (HPV) vaccination.

Sharing Knowledge About Immunisation (SKAI): Talking with parents about human papillomavirus (HPV) vaccination 

To learn more about HPV, visit MVEC: HPV. 

经过 艾丽丝·布莱克

TGA: 2026 Seasonal Influenza Vaccines

On 4 March, the Therapeutic Goods Administration (TGA) published its 2026 Seasonal Influenza Vaccines report. 

The report covers the 2026 seasonal influenza vaccines, with information on vaccines by age group, vaccine ingredients and co-administration. 

For more information, visit MVEC：流感.

经过 艾丽丝·布莱克

ATAGI: Statement on the administration of seasonal influenza vaccines in 2026

On 27 February, the national Department of Health and Aged Care released the ATAGI statement on the administration of seasonal influenza vaccines in 2026.

Influenza vaccines are recommended annually and are funded on the National Immunisation Program (NIP) for:

• children aged 6 months to less than 5 years 
• all adults aged 65 years and older 
• specific populations aged 5 to 64 years who are at greatest risk of developing complications from influenza infection (including pregnant women, First Nations people, and those with certain medical risk factors). 

For more details, refer to ATAGI’s full statement, and MVEC’s influenza reference page which has been updated for the 2026 influenza season. 

经过 艾丽丝·布莱克

Australian Immunisation Handbook: Pregnant women are recommended to receive an RSV vaccine during each pregnancy to protect their infant

Following its introduction for pregnant people in Australia last year, the RSV vaccination is now recommended in each pregnancy. 

MVEC has accordingly updated our ‘Vaccines in pregnancy’ A4 flyer. 

To read the recommendation in full, visit Australian Immunisation Handbook: Pregnant women are recommended to receive an RSV vaccine during each pregnancy to protect their infant. 

For more information, visit MVEC：呼吸道合胞病毒（RSV） 

经过 艾丽丝·布莱克